AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
13.73
+0.30 (2.23%)
At close: Jun 26, 2026, 4:00 PM EDT
13.81
+0.08 (0.58%)
After-hours: Jun 26, 2026, 4:10 PM EDT
AgomAb Therapeutics NV Employees
AgomAb Therapeutics NV had 62 employees as of December 31, 2025. The number of employees increased by 4 or 7.27% compared to the previous year.
Employees
62
Change (1Y)
4
Growth (1Y)
7.27%
Revenue / Employee
n/a
Profits / Employee
-$1,467,672
Market Cap
680.11M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 62 | 4 | 7.27% |
| Dec 31, 2024 | 58 | 24 | 70.00% |
| Dec 31, 2023 | 34 | 33 | 3,300.00% |
| Dec 31, 2019 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| Rigel Pharmaceuticals | 174 |
| Allogene Therapeutics | 152 |
| Aclaris Therapeutics | 73 |
| SpyGlass Pharma | 68 |
| Oculis Holding AG | 60 |
| Candel Therapeutics | 55 |
| Immix Biopharma | 21 |
AGMB News
- 4 days ago - Agomab announces NOV-ERA study design - TheFly
- 4 days ago - Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn's Disease - GlobeNewsWire
- 6 days ago - Agomab initiated with a Buy at H.C. Wainwright - TheFly
- 4 weeks ago - Agomab Announces Results of Annual General Meeting - GlobeNewsWire
- 6 weeks ago - Agomab to Participate in Upcoming Conferences - GlobeNewsWire
- 2 months ago - Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook - GlobeNewsWire
- 2 months ago - AgomAb Therapeutics NV Earnings release: Q4 2025 - Filings
- 2 months ago - AgomAb Therapeutics NV Annual report: Q4 2025 - Filings